- Home
- CAL vs VIR Comparison
CAL vs VIR Comparison
Compare CAL & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAL
- VIR
- Stock Information
- Founded
- CAL 1878
- VIR 2016
- Country
- CAL United States
- VIR United States
- Employees
- CAL N/A
- VIR N/A
- Industry
- CAL Shoe Manufacturing
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- CAL Consumer Discretionary
- VIR Health Care
- Exchange
- CAL Nasdaq
- VIR Nasdaq
- Market Cap
- CAL 520.3M
- VIR 844.9M
- IPO Year
- CAL N/A
- VIR 2019
- Fundamental
- Price
- CAL $13.89
- VIR $5.43
- Analyst Decision
- CAL Hold
- VIR Strong Buy
- Analyst Count
- CAL 1
- VIR 7
- Target Price
- CAL $14.00
- VIR $32.86
- AVG Volume (30 Days)
- CAL 1.0M
- VIR 1.1M
- Earning Date
- CAL 05-29-2025
- VIR 07-31-2025
- Dividend Yield
- CAL 2.03%
- VIR N/A
- EPS Growth
- CAL N/A
- VIR N/A
- EPS
- CAL 2.43
- VIR N/A
- Revenue
- CAL $2,677,706,000.00
- VIR $20,861,000.00
- Revenue This Year
- CAL N/A
- VIR N/A
- Revenue Next Year
- CAL $3.48
- VIR N/A
- P/E Ratio
- CAL $5.68
- VIR N/A
- Revenue Growth
- CAL N/A
- VIR N/A
- 52 Week Low
- CAL $12.09
- VIR $4.32
- 52 Week High
- CAL $44.51
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- CAL 52.67
- VIR 56.02
- Support Level
- CAL $12.14
- VIR $4.91
- Resistance Level
- CAL $12.83
- VIR $5.35
- Average True Range (ATR)
- CAL 0.69
- VIR 0.26
- MACD
- CAL 0.16
- VIR 0.02
- Stochastic Oscillator
- CAL 98.90
- VIR 98.11
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.